Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 5 of 142 posts
November 9, 2021 | Blogs
Are Current Reimbursement Options for Opioid Use Disorder DTx Causing a Barrier to Widespread Adoption in the USA?
CBPartners' Digital Therapeutics and Health Technology Expertise Team investigates reimbursement for Opioid Use Disorder (OUD) DTx in the US.
November 2, 2021 | Blogs
Historically there has been limited competition for biologic drugs resulting in fewer choices and higher prices for patients. This analysis explores insulin products in the USA and EU to compare the approval pathways.
October 27, 2021 | Blogs
Despite surpassing the challenge of FDA approval, there are now a wide range of implications for health care access and coverage in the U.S for aducanumab, a treatment for Alzheimer's Disease.
October 19, 2021 | Blogs
Explore themes from biotech and investors in the cell and gene therapy space, as well as future-facing cell and gene therapy trends, new developments in the space, as well as what’s next.
October 14, 2021 | Culture Blog, News
CBPartners collaborated with Inspire! to give London-based students aged 14-16 exposure to life sciences consulting.